Electra amasses $350M in biotech’s latest big IPO
Source ↗
👁 0
💬 0
Nearly a dozen biotechnology firms have matched or raised more than $300 million in their initial public offerings in 2026, a figure not seen since new stock sales peaked in 2021, according to BioPharma Dive data.
Comments (0)